KMID : 1039320210210010045
|
|
Journal of Liver Cancer 2021 Volume.21 No. 1 p.45 ~ p.57
|
|
Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ¡Ã13 cm
|
|
Hwang Shin
Kim Ki-Hun Moon Deok-Bog Ahn Chul-Soo Ha Tae-Yong Song Gi-Won Jung Dong-Hwan Park Gil-Chun
|
|
Abstract
|
|
|
Background/Aims: Multiplication of ¥á-fetoprotein, des-¥ã-carboxy prothrombin, and tumor volume (ADV score) is a surrogate marker for post-resection prognosis of hepatocellular carcinoma (HCC). This study aimed to validate the predictive power of the ADV score-based prognostic prediction model for patients with solitary huge HCC.
Methods: Of 3,018 patients, 100 patients who underwent hepatic resection for solitary HCC ¡Ã13 cm between 2008 and 2012 were selected.
Results: The median tumor diameter and tumor volume were 15.0 cm and 886 mL, respectively. Tumor recurrence and overall survival (OS) rates were 70.7% and 66.0% at one year and 84.9% and 34.0% at five years, respectively. Microvascular invasion (MVI) was the only independent risk factor for disease-free survival (DFS) and OS. DFS and OS, stratified by ADV score with 1-log intervals, showed significant prognostic contrasts (P=0.007 and P=0.017, respectively). DFS and OS, stratified by ADV score with a cut-off of 8-log, showed significant prognostic contrasts (P=0.014 and P=0.042, respectively). The combination of MVI and ADV score with a cut-off of 8-log also showed significant prognostic contrasts in DFS (P<0.001) and OS (P=0.001) considering the number of risk factors. Prognostic contrast was enhanced after combining the MVI and ADV score.
Conclusions: The prognostic prediction model with the ADV score could reliably predict the risk of tumor recurrence and long-term patient survival outcomes in patients with solitary huge HCC ¡Ã13 cm. The results of this study suggest that our prognostic prediction models can be used to guide surgical treatment and post-resection follow-up for patients with huge HCCs.
|
|
KEYWORD
|
|
Hepatocellular carcinoma, Resection, Recurrence, Microvascular invasion, Tumor biology
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|